|Articles|April 1, 2013
- Pharmaceutical Executive-04-01-2013
- Volume 0
- Issue 0
PE, April 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
over 12 years ago
Country Report: Belgiumover 12 years ago
On-Market Pricing Strategiesover 12 years ago
Is National Drug Pricing Freedom in Europe Nearing its Expiry Date?over 12 years ago
Evidence-Based Marketing: From Rise to Stall—and Ultimate Triumphover 12 years ago
Pfizer's Quality by Design Approach to Trial Managementover 12 years ago
Woman of the Year 2013over 12 years ago
Key to Brand Positioning: Look Inside Your Heartover 12 years ago
Full Disclosure for PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
How will DTC Programs Impact PBMs?
5
